Vyvanse 30 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F47MP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,592
Award facts
- Contract value 100% obligated
- $18,591.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, the subsidiary pharmaceutical distributor of parent company Cencora, Inc., has been awarded a delivery order by the Defense Logistics Agency for 100 capsules of Vyvanse 30 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. The contract, awarded on January 20, 2026, carries a ceiling value of $18,591.61 with a firm fixed-price structure and an ultimate completion date of January 21, 2026. This award was made on a competitive, non-set-aside basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. That primary vehicle authorizes the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Medical Supply Chain utilizes such contracts to efficiently fulfill pharmaceutical requirements for military treatment facilities and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F47MP?
SPE2DR26F47MP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F47MP worth?
The government has obligated $18,592 on SPE2DR26F47MP.
Is contract SPE2DR26F47MP an order under another contract?
Yes. SPE2DR26F47MP is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47MP competed?
The extent of competition for SPE2DR26F47MP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award